STMN1 as A Potential Drug Target and Biomarker for Neurodegenerative Disorders

Target Name: STMN1

NCBI ID: G3925

STMN1

STMN1 as A Potential Drug Target and Biomarker for Neurodegenerative Disorders

STMN1 (STMN1_HUMAN), a gene that encodes for a protein known as STMN1, has been identified as a potential drug target and biomarker for a variety of diseases, including heart failure, cancer, and neurodegenerative disorders.

The STMN1 gene has been shown to play a crucial role in the structure and function of the heart muscle. When the STMN1 gene is expressed in heart muscle cells, it promotes the formation of new cardiac muscle cells, helps to maintain the heart muscle's contractile function, and is involved in the development and maintenance of the heart's electrical activity.

Research has also shown that STMN1 is involved in the regulation of cell growth and division, and that it can help to prevent the formation of cancer cells. In addition, STMN1 has been shown to be involved in the development and progression of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

Due to these findings, STMN1 has been identified as a potential drug target for a variety of diseases. One approach to targeting STMN1 is to use small molecules, such as drugs that can modulate the activity of the STMN1 gene. These small molecules have been shown to be effective in animal models of a variety of neurodegenerative disorders, including Alzheimer's disease and Parkinson's disease.

Another approach to targeting STMN1 is to use antibodies that can bind to the STMN1 protein and prevent it from participating in the formation of new cardiac muscle cells or from regulating the activity of cell growth and division. These antibodies have been shown to be effective in animal models of heart failure and cancer, and may be a promising approach to treating these diseases.

In addition to its potential as a drug target, STMN1 has also been identified as a potential biomarker for a variety of diseases. The STMN1 gene has been shown to be expressed in the heart muscle, and its levels have been used as a marker for the diagnosis of heart failure. In addition, the STMN1 gene has been shown to be involved in the regulation of cell growth and division, and its levels have been used as a marker for the diagnosis of cancer.

Overall, the STMN1 gene has shown to be a promising target for the development of new drugs and therapies for a variety of neurodegenerative disorders, including heart failure, cancer, and Alzheimer's disease. Further research is needed to fully understand the role of STMN1 in these diseases and to develop safe and effective treatments.

Protein Name: Stathmin 1

Functions: Involved in the regulation of the microtubule (MT) filament system by destabilizing microtubules. Prevents assembly and promotes disassembly of microtubules. Phosphorylation at Ser-16 may be required for axon formation during neurogenesis. Involved in the control of the learned and innate fear (By similarity)

The "STMN1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about STMN1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets